In summary, our study showed that increased CRP and LDH were risk factors for severe events in all enrolled COVID-19 patients, and there was an increased incidence of hypoalbuminemia complications and longer hospitalization for COVID-19 cancer patients without anticancer treatment undergoing regular follow-up compared with noncancer patients. The gene discussed is CRP; the disease is Hypoalbuminemia.